Topics

Indivior loses appeal to block generic Suboxone opioid treatments

10:43 EDT 12 Jul 2019 | Reuters

A divided federal appeals court on Friday ruled against Indivior Plc in its bid to stop Dr. Reddy's Laboratories Ltd and Alvogen from selling generic versions of its opioid addiction treatment Suboxone film that infringed its patents.

Original Article: Indivior loses appeal to block generic Suboxone opioid treatments

NEXT ARTICLE

More From BioPortfolio on "Indivior loses appeal to block generic Suboxone opioid treatments"

Quick Search

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...